Invivyd Inc.

10/29/2024 | Press release | Distributed by Public on 10/29/2024 06:42

Invivyd Phase 3 Long Term Exploratory Clinical Efficacy Data Shows PEMGARDA™ (pemivibart) Provided Substantial Protection from Symptomatic COVID 19 Versus Placebo Over Six[...]